Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference Product

    Details
    Basic Details
    Date
    Saturday, January 30, 2021
    Entity
    BBCIC
    Type
    Publication
    Description

    Data on short-acting recombinant granulocyte colony-stimulating factor (G-CSF) biosimilar utilization from claims data in the USA are limited. The objective was to evaluate patient baseline characteristics and utilization patterns for short-acting G-CSF products with a particular focus on the assessment of filgrastim biosimilar usage relative to the originator product. We examined filgrastim, filgrastim-sndz, and tbo-filgrastim use among adult patients between January 2012 and March 2019 across the five health-plan research partners in the BBCIC Distributed Research Network. The publicly available Sentinel System analytic toolkit was used to perform the distributed analyses.

    Contributors
    Author(s)

    Aaron B. Mendelsohn, James Marshall, Cara L McDermott, Pamala A. Pawloski, Jeffrey S. Brown, Catherine M. Lockhart